Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03826147 · ClinicalTrials.gov registry record · Phase 4
Nitrite-boosting Therapy for Improving Physiological Function in Patients With Chronic Kidney Disease
A Phase 4 study, sponsored by University of Colorado, Boulder.
- Active
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
NCT03826147 is a Phase 4 study that is active but no longer recruiting, run by University of Colorado, Boulder. The registered enrollment target is 92 participants.
The verdict
NCT03826147, a Phase 4 study, is active but no longer recruiting, sponsored by University of Colorado, Boulder.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
Study Summary
Nitric oxide (NO) is an essential molecule in the body that is decreased in patients with chronic kidney disease (CKD), leading to reductions in vascular, movement ("motor") and cognitive functions. This study will determine if daily oral supplementation (3 months) with a supplement that increases NO in the body, i.e., nitrate-rich beetroot juice, improves vascular, motor and cognitive function in patients with CKD; this study will also provide insight into the biological reasons (mechanisms) by which supplementation with nitrate-rich beetroot juice improves vascular function in these patients. Overall, this research will provide scientific evidence supporting the use of nitrate-rich beetroot juice for preserving physiological function and preventing co-morbid clinical conditions and disability in CKD.
Interventions
- DIETARY_SUPPLEMENT Nitrate-rich beetroot juice
- DIETARY_SUPPLEMENT Nitrate-depleted beetroot juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03826147
The ClinicalTrials.gov registry entry for NCT03826147 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nitrate-rich beetroot juice is the first listed.
NCT03826147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03826147 about?
NCT03826147 is a clinical study titled "Nitrite-boosting Therapy for Improving Physiological Function in Patients With Chronic Kidney Disease". Nitric oxide (NO) is an essential molecule in the body that is decreased in patients with chronic kidney disease (CKD), leading to reductions in vascular, movement ("motor") and cognitive functions. This study will determine if daily oral supplementation (3 months) with a supplement that increases N...
What is the current status of trial NCT03826147?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2019-05-01. Estimated completion is 2026-08.
What interventions are being tested in trial NCT03826147?
The interventions under investigation include: Nitrate-rich beetroot juice (DIETARY_SUPPLEMENT), Nitrate-depleted beetroot juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03826147?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.